Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 7:22 pm Sale |
2024-09-30 | 13G | ALX Oncology Holdings Inc. ALXO |
ORBIMED ADVISORS LLC | 0 0.000% |
-2,255,000 (Position Closed) |
Filing History |
| 2024-11-14 6:45 pm Sale |
2024-09-30 | 13G | Elevation Oncology, Inc. ELEV |
ORBIMED ADVISORS LLC | 2,441,275 4.000% |
-558,725 (-18.62%) |
Filing History |
| 2024-11-14 6:43 pm Purchase |
2024-09-30 | 13G | Avalo Therapeutics, Inc. AVTX |
ORBIMED ADVISORS LLC | 2,925,900 4.200% |
2,925,900 (New Position) |
Filing History |
| 2024-11-14 6:41 pm Purchase |
2024-09-30 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
ORBIMED ADVISORS LLC | 589,200 4.900% |
589,200 (New Position) |
Filing History |
| 2024-11-14 6:35 pm Unchanged |
2024-09-30 | 13G | InspireMD, Inc. NSPR |
ORBIMED ADVISORS LLC | 2,133,405 8.300% |
0 (Unchanged) |
Filing History |
| 2024-11-14 6:30 pm Sale |
2024-09-30 | 13G | NeuroPace, Inc. NPCE |
ORBIMED ADVISORS LLC | 3,406,335 11.700% |
-597,632 (-14.93%) |
Filing History |
| 2024-11-14 6:25 pm Purchase |
2024-09-30 | 13G | Verastem, Inc. VSTM |
ORBIMED ADVISORS LLC | 4,148,862 9.900% |
2,619,747 (+171.32%) |
Filing History |
| 2024-11-14 6:23 pm Purchase |
2024-09-30 | 13G | Avalo Therapeutics, Inc. AVTX |
ORBIMED ADVISORS LLC | 967,000 9.900% |
967,000 (New Position) |
Filing History |
| 2024-11-12 6:04 pm Unchanged |
2024-11-07 | 13D | Third Harmonic Bio, Inc. THRD |
ORBIMED ADVISORS LLC | 5,779,071 12.800% |
0 (Unchanged) |
Filing History |
| 2024-11-12 5:23 pm Unchanged |
2024-11-07 | 13D | Edgewise Therapeutics, Inc. EWTX |
ORBIMED ADVISORS LLC | 14,756,096 15.600% |
0 (Unchanged) |
Filing History |
| 2024-11-08 7:15 pm Purchase |
2024-11-01 | 13D | Lomond Therapeutics Holdings, Inc. | ORBIMED ADVISORS LLC | 2,677,256 9.800% |
2,677,256 (New Position) |
Filing History |
| 2024-11-06 4:12 pm Purchase |
2024-09-16 | 13D | Traws Pharma, Inc. TRAW |
ORBIMED ADVISORS LLC | 605,531 19.900% |
3,531 (+0.59%) |
Filing History |
| 2024-10-25 4:24 pm Sale |
2024-10-23 | 13D | TELA Bio, Inc. TELA |
ORBIMED ADVISORS LLC | 1,182,717 4.800% |
-941,550 (-44.32%) |
Filing History |
| 2024-10-17 4:16 pm Purchase |
2024-10-15 | 13D | Upstream Bio, Inc. UPB |
ORBIMED ADVISORS LLC | 4,554,873 8.900% |
4,554,873 (New Position) |
Filing History |
| 2024-10-01 5:35 pm Sale |
2024-09-27 | 13D | TELA Bio, Inc. TELA |
ORBIMED ADVISORS LLC | 2,124,267 8.600% |
-313,700 (-12.87%) |
Filing History |
| 2024-09-23 6:44 pm Purchase |
2024-09-16 | 13D | Traws Pharma, Inc. TRAW |
ORBIMED ADVISORS LLC | 602,000 19.900% |
602,000 (New Position) |
Filing History |
| 2024-09-23 4:34 pm Purchase |
2024-09-16 | 13D | MBX Biosciences, Inc. Common Stock MBX |
ORBIMED ADVISORS LLC | 3,812,215 12.000% |
3,812,215 (New Position) |
Filing History |
| 2024-09-16 8:29 pm Unchanged |
2024-09-12 | 13D | Terns Pharmaceuticals, Inc. TERN |
ORBIMED ADVISORS LLC | 7,562,971 9.000% |
0 (Unchanged) |
Filing History |
| 2024-09-10 4:12 pm Unchanged |
2024-09-03 | 13D | Xtant Medical Holdings, Inc. XTNT |
ORBIMED ADVISORS LLC | 73,114,592 52.700% |
0 (Unchanged) |
Filing History |
| 2024-08-15 4:47 pm Purchase |
2024-08-13 | 13D | scPharmaceuticals Inc. SCPH |
ORBIMED ADVISORS LLC | 6,059,528 12.100% |
500,000 (+8.99%) |
Filing History |